经皮穴位电刺激治疗正常高值血压:随机对照预试验研究方案
干预组每周4次、每次30分钟、共12周48次家庭TEAS,主要结局为12周平均收缩压较基线变化,并评估可行性及安全性。
要点
- TEAS联合生活方式干预正常高值血压,每周4次、每次30分钟、共12周48次。
- 主要结局为12周平均收缩压较基线变化,次要结局含舒张压、高血压进展比例等。
- 本试验为预试验,旨在评估可行性和为完整随机对照试验提供依据。
核心结论
- 本预试验将探索TEAS联合生活方式干预正常高值血压的可行性和潜在有效性及安全性。
- 该预试验旨在为开展完整规模的确定性随机对照试验提供可行性依据。
研究设计与样本
- 前瞻性、随机、平行对照临床试验,在中国一个社区卫生服务中心开展。
关键数值与推荐
- 干预组除生活方式干预外,接受TEAS四个穴位、每次30分钟、每周4次、共12周、总计48次家庭治疗。
- 主要结局为12周时平均收缩压较基线变化。
- 次要结局包括平均舒张压变化、进展为高血压的受试者比例、生活质量、体质指数和腰围。
- 试验期间监测不良事件。
临床怎么用
- 若证实有效且安全,TEAS联合生活方式干预可能成为正常高值血压的非药物控制选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-normal blood pressure (BP) is associated with increased all-cause, cardiovascular mortality and frequently progresses to hypertension. Transcutaneous electrical acupoint stimulation (TEAS) might be a non-pharmaceutical therapy option to control BP. This trial aims to determine the effectiveness and safety of TEAS combined with lifestyle modification for high-normal BP. METHODS/DESIGN: This prospective, randomized, and parallel clinical trial will be conducted in a community service center in China. Sixty participants with high-normal BP will be randomly allocated to receive TEAS plus lifestyle modification (intervention group) or lifestyle modification alone (control group) in a 1:1 ratio. In addition to lifestyle modification, the intervention group will receive TEAS at four acupoints for 30 min, 4 times weekly for 12 weeks for a total of 48 sessions at home. The control group will receive same lifestyle modification but no TEAS. The primary outcome will be the change in mean systolic blood pressure at 12 weeks from the baseline measurement. Secondary outcomes include the change of mean diastolic blood pressure, proportion of subjects with progression to hypertension, quality of life, body mass index, and waist circumference. Adverse events during the trial will be monitored. DISCUSSION: This trial will explore the feasibility and provide potential evidence for the effectiveness and safety of TEAS plus lifestyle modification for high-normal BP. Furthermore, this pilot trial is being undertaken to determine the feasibility of a full scale definitive randomized controlled trial. The results of this study will be published in a peer-reviewed journal. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR 1900024982 . Registered on August 6, 2019.
引用
- Wang Y, Shi GX, Tian ZX, et al. Transcutaneous electrical acupoint stimulation for high-normal blood pressure: study protocol for a randomized controlled pilot trial. Trials. 2021. PMID: 33588904. doi:10.1186/s13063-021-05039-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。